U.S. student pharmacists perspectives on the pharmacogenomics of escitalopram and aripiprazole
{{output}}
Major depressive disorder (MDD) remains a significant illness worldwide, yet antidepressant therapy often follows an empirical "trial-and-error" approach. Escitalopram, a selective serotonin reuptake inhibitor is approved for MDD and generalized anxiety diso... ...
